Orivam News from the source.

Galaxy Surfactants Limited

NSE GALAXYSURF BSE 540935 INE600K01018

0 filings · 0 analysed

2,197.10 -12.19% over 1 month
2,200 2,400 2,600 09 Oct 15 Oct 22 Oct 28 Oct 03 Nov 09 Nov
  1. HSIE Results Daily 06 Nov 26 HSIE

    HDFC Securities ADD target INR2,775 +0.00% in 1h

    The report says Galaxy Surfactants' Q2 EBITDA/APAT were above estimates aided by a new Unilever framework agreement and a BASF-related market opportunity, maintaining ADD with TP INR2,775.

  2. Chemicals Q2FY27 Results Preview HSIE

    HDFC Securities ADD target Rs 2,775 +0.00% in 1h

    The report expects per-unit EBITDA to fall to INR 24.5/kg from INR 35.0/kg in Q1 despite 32.8% YoY revenue growth.

Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.

Targets, and what happened next

What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.

HousePublishedCall EntryTarget NowProgress Standing
HDFC Securities 14 Oct 2026, 15:45 long 2,609.30 2,775.00 2,179.10 -100% open by 2027-10-14

Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.

What the desks said

06 Nov 2026, 06:42 IST HDFC Securities ADD target INR2,775

The report says Galaxy Surfactants' Q2 EBITDA/APAT were above estimates aided by a new Unilever framework agreement and a BASF-related market opportunity, maintaining ADD with TP INR2,775.

Read this note →
14 Oct 2026, 15:45 IST HDFC Securities ADD target Rs 2,775

The report expects per-unit EBITDA to fall to INR 24.5/kg from INR 35.0/kg in Q1 despite 32.8% YoY revenue growth.

Read this note →
08 Oct 2026, 14:15 IST HDFC Securities (HSIE Research) via HDFC Securities ADD (upgraded from REDUCE) target INR 2,775

The note says Galaxy Surfactants is entering a structurally stronger growth phase, with HSIE forecasting revenue/EBITDA/APAT CAGR of 10/14/20% over FY26-FY29E and RoE improving 306bps to 13.5% in FY29, aided by the Unilever strategic framework agreement and volumes freed up by BASF's Dahej sulfation plant closure, with the stock trading at 21.7/21.2/18.9x FY27/28/29E EPS versus an 8-year average 1-year forward PE of ~27x.

Read this note →

Announcement timeline

No filings stored for this company yet.

Never miss the next one.

Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.

Get the daily brief